Cullinan Therapeutics, Inc. (CGEM) stock
CGEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$10.19−1.16 (-10.22%)
Close on Nov 12, 2026Market cap $655.77MP/E –Yield –
Cullinan Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Cullinan Therapeutics's profit margin for the twelve months ending Dec 31, 2021 was -346.1%. For fiscal 2021 it was -346.1%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -346.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2021 | Mar 31, 2021 | -0.4% | – |
See a number that looks wrong?